Hospitalizations in pediatric patients with immune thrombocytopenia in the United States

References

• Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med 2002;346:995–1008.
   PubMed Web of Science ®Google Scholar
• Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, Bussel JB, Cines DB, Chong BH, Cooper N, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: Report from an international working group. Blood 2009;113:2386–2393.
   Google Scholar
• Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, Chong BH, Cines DB, Gernsheimer TB, Godeau B, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010;115:168–186.
   Google Scholar
• Chu YW, Korb J, Sakamoto KM. Idiopathic thrombocytopenic purpura. Pediatr Rev 2000;21:95–104.
   PubMedGoogle Scholar
• Zeller B, Helgestad J, Hellebostad M, Kolmannskog S, Nystad T, Stensvold K, Wesenberg F. Immune thrombocytopenic purpura in childhood in Norway: A prospective, population-based registration. Pediatr Hematol Oncol 2000;17:551–558.
   PubMed Web of Science ®Google Scholar
• Glanz J, France E, Xu S, Hayes T, Hambidge S. A population-based, multisite cohort study of the predictors of chronic idiopathic thrombocytopenic purpura in children. Pediatrics 2008;121:e506–e512.
   PubMed Web of Science ®Google Scholar
• Segal JB, Powe NR. Prevalence of immune thrombocytopenia: Analyses of administrative data. J Thromb Haemost 2006;4:2377–2383.
   PubMed Web of Science ®Google Scholar
• Feudjo-Tepie MA, Robinson NJ, Bennett D. Prevalence of diagnosed chronic immune thrombocytopenic purpura in the US: Analysis of a large US claim database: A rebuttal. J Thromb Haemost 2008;6:711–713.
   PubMed Web of Science ®Google Scholar
• Walker RW, Walker W. Idiopathic thrombocytopenia, initial illness and long term follow up. Arch Dis Child 1984;59:316–322.
   PubMed Web of Science ®Google Scholar
• Sutor AH, Harms A, Kaufmehl K. Acute immune thrombocytopenia (ITP) in childhood: Retrospective and prospective survey in Germany. Semin Thromb Hemost 2001;27:253–267.
   PubMed Web of Science ®Google Scholar
• Kühne T, Imbach P, Bolton-Maggs PH, Berchtold W, Blanchette V, Buchanan GR. Newly diagnosed idiopathic thrombocytopenic purpura in childhood: An observational study. Lancet 2001;358:2122–2125.
   PubMed Web of Science ®Google Scholar
• Tamminga R, Berchtold W, Bruin M, Buchanan GR, Kühne T. Possible lower rate of chronic ITP after IVIG for acute childhood ITP an analysis from registry I of the Intercontinental Cooperative ITP Study Group (ICIS). Br J Haematol 2009;146:180–184.
   PubMed Web of Science ®Google Scholar
• Kühne T, Buchanan GR, Zimmerman S, Michaels LA, Kohan R, Berchtold W, Imbach P, Intercontinental Childhood ITP Study Group, Intercontinental Childhood ITP Study Group. A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the Intercontinental Childhood ITP Study Group. J Pediatr 2003;143:605–608.
   Google Scholar
• Donato H, Picón A, Martinez M, Rapetti MC, Rosso A, Gomez S, Rossi N, Bacciedoni V, Schvartzman G, Riccheri C, et al. Demographic data, natural history, and prognostic factors of idiopathic thrombocytopenic purpura in children: A multicentered study from Argentina. Pediatr Blood Cancer 2009;52:491–496.
   PubMed Web of Science ®Google Scholar
• Imbach P, Kühne T, Müller D, Berchtold W, Zimmerman S, Elalfy M, Buchanan GR. Childhood ITP: 12 months follow-up data from the prospective registry I of the Intercontinental Childhood ITP Study Group (ICIS). Pediatr Blood Cancer 2006;46:351–356.
   PubMed Web of Science ®Google Scholar
• Neunert CE, Buchanan GR, Imbach P, Bolton-Maggs PHB, Bennett CM, Neufeld EJ, Vesely SK, Adix L, Blanchette VS, Kühne T, et al. Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura. Blood 2008;112:4003–4008.
   PubMed Web of Science ®Google Scholar
• Neunert CE, Buchanan GR, Imbach P, Bolton-Maggs PHB, Bennett CM, Neufeld E, Vesely SK, Adix L, Blanchette VS, Kühne T, et al. Bleeding manifestations and management of children with persistent and chronic immune thrombocytopenia: Data from the Intercontinental Cooperative ITP Study Group (ICIS). Blood 2013;121:4457–4462.
   PubMed Web of Science ®Google Scholar
• Buchanan GR, Adix L. Grading of hemorrhage in children with idiopathic thrombocytopenic purpura. J Pediatr 2002;141:683–688.
   PubMed Web of Science ®Google Scholar
• Medeiros D, Buchanan GR. Major hemorrhage in children with idiopathic thrombocytopenic purpura: Immediate response to therapy and long-term outcome. J Pediatr 1998;133:334–339.
   PubMed Web of Science ®Google Scholar
• Kühne T, Berchtold W, Michaels LA, Wu R, Donato H, Espina B, Tamary H, Rodeghiero F, Chitlur M, Rischewski J, et al. Newly diagnosed immune thrombocytopenia in children and adults: A comparative prospective observational registry of the Intercontinental Cooperative Immune Thrombocytopenia Study Group. Haematologica 2011;96:1831–1837.
   PubMed Web of Science ®Google Scholar
• Psaila B, Petrovic A, Page LK, Menell J, Schonholz M, Bussel JB. Intracranial hemorrhage (ICH) in children with immune thrombocytopenia (ITP): Study of 40 cases. Blood 2009;114:4777–4783.
   PubMed Web of Science ®Google Scholar
• Kühne T, Blanchette V, Buchanan GR, Ramenghi U, Donato H, Tamminga RYJ, Rischewski J, Berchtold W, Imbach P, Intercontinental Childhood ITP Study Group. Splenectomy in children with idiopathic thrombocytopenic purpura: A prospective study of 134 children from the Intercontinental Childhood ITP Study Group. Pediatr Blood Cancer 2007;49:829–834.
   Google Scholar
• Neunert CE, Bright BC, Buchanan GR. Severe chronic refractory immune thrombocytopenic purpura during childhood: a survey of physician management. Pediatr Blood Cancer 2008;51:513–516.
   PubMed Web of Science ®Google Scholar
• Vesely SK, Buchanan GR, Adix L, George JN, Cohen AR, Blanchette VS, Kühne T, American Society of Pediatric Hematology/Oncology, 2001. Self-reported initial management of childhood idiopathic thrombocytopenic purpura: Results of a survey of members of the American Society of Pediatric Hematology/Oncology, 2001. J Pediatr Hematol Oncol 2003;25:130–133.
   Google Scholar
• Vesely SK, Buchanan GR, Cohen A, Raskob G, George J. Self-reported diagnostic and management strategies in childhood idiopathic thrombocytopenic purpura: Results of a survey of practicing pediatric hematology/oncology specialists. J Pediatr Hematol Oncol 2000;22:55–61.
   PubMed Web of Science ®Google Scholar
• Bolton-Maggs P, Tarantino MD, Buchanan GR, Bussel JB, George JN. The child with immune thrombocytopenic purpura: Is pharmacotherapy or watchful waiting the best initial management? A panel discussion from the 2002 meeting of the American Society of Pediatric Hematology/Oncology. J Pediatr Hematol Oncol 2004;26:146–151.
   PubMed Web of Science ®Google Scholar
• Thompson JC, Klima J, Despotovic JM, O’Brien SH. Anti-D immunoglobulin therapy for pediatric ITP: Before and after the FDA’s black box warning. Pediatr Blood Cancer 2013;60:E149–E151.
   PubMed Web of Science ®Google Scholar
• Ancona KG, Parker RI, Atlas MP, Prakash D. Randomized trial of high-dose methylprednisolone versus intravenous immunoglobulin for the treatment of acute idiopathic thrombocytopenic purpura in children. J Pediatr Hematol Oncol 2002;24:540–544.
   PubMed Web of Science ®Google Scholar
• Dalakas MC. Intravenous immune globulin therapy for neurologic diseases. Ann Intern Med 1997;126:721–730.
   PubMed Web of Science ®Google Scholar
• Ji X. Treatment progress of idiopathic thrombocytopenic purpura. Chin J Thromb Haemost 2004;10:41–45.
   Google Scholar
• Aronis S, Platokouki H, Avgeri M, Pergantou H, Keramidas D. Retrospective evaluation of long-term efficacy and safety of splenectomy in chronic idiopathic thrombocytopenic purpura in children. Acta Paediatr 2004;93:638–642.
   PubMed Web of Science ®Google Scholar
• Introduction to the KID Healthcare Cost Utilization Project (HCUP) [Internet]. Rockiville (MD): Agency for Healthcare Research and Quality Healthcare Cost and Utilization Project (HCUP). 2009 - [cited 2015 Sep 24]. Available from: http://www.hcup-us.ahrq.gov/db/nation/kid/KID_2009_Introduction.pdf
   Google Scholar
• HCUP KID Database Documentation [Internet]. Rockiville (MD): Agency for Healthcare Research and Quality Healthcare Cost and Utilization Project (HCUP). 2014 - [cited 2015 Sep 24]. Available from: http://www.hcup-us.ahrq.gov/db/nation/kid/kiddbdocumentation.jsp
   Google Scholar
• Danese MD, Lindquist K, Gleeson M, Deuson R, Mikhael J. Cost and mortality associated with hospitalizations in patients with immune thrombocytopenic purpura. Am J Hematol 2009;84:631–635.
   Google Scholar
• Elixhauser A, Steiner C, Palmer L, Clinical Classifications Software (CCS). Rockville (MD): Agency for Healthcare Research and Quality Healthcare Cost and Utilization Project (HCUP). 2012. Available from: http://www.hcup-us.ahrq.gov/tools_software.jsp
   Google Scholar
• HCUP-US Cost-to-Charge Ratio Files [Internet]. Rockiville (MD): Agency for Healthcare Research and Quality Healthcare Cost and Utilization Project (HCUP). 2014. Available from: http://www.hcup-us.ahrq.gov/db/state/costtocharge.jsp
   Google Scholar
• Health Outcomes of Interest [Internet].Observational Medical Outcomes Partnership. 2013. Available from: http://omop.org/HOI
   Google Scholar
• Kime C, Klima J, Rose MJ, O’Brien SH. Patterns of inpatient care for newly diagnosed immune thrombocytopenia in US children’s hospitals. Pediatrics 2013;131:880–885.
   PubMed Web of Science ®Google Scholar
• Neunert C, Lim W, Crowther M, Cohen A, Solberg L Jr, Crowther MA, American Society of Hematology. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 2011;117:4190–4207.
   Google Scholar